Form4insider filings, from the source

SEC Form 4 · accession 0000914190-17-000238

BIO-TECHNE Corp · TECH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Charles R. Kummeth
Officer — Chief Executive Officer · Director
Period of report
Aug 12, 2017
Accepted (ET)
Aug 15, 2017 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Aug 12, 2017M9,248—A70,278D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F7,F6$94.35Aug 12, 2017A66,849A—Aug 12, 2021Common Stock66,84966,849D
Stock Option (Right to Buy)F4$67.46holding————Apr 1, 2020Common Stock65,00065,000D
Stock Option (Right to Buy)F4$67.46holding————Apr 1, 2020Common Stock50,00050,000D
Stock Option (Right to Buy)F5$86.25holding————Apr 1, 2021Common Stock46,31646,316D
Stock Option (Right to Buy)F8$108.49holding————Aug 7, 2022Common Stock79,51779,517D
Stock Option (Right to Buy)F9$108.49holding————Aug 7, 2022Common Stock119,275119,275D
Restricted Stock UnitF10,F9—holding—————Common Stock17,28317,283D
Stock Option (Right to Buy)F11$106.59holding————Aug 18, 2023Common Stock102,779102,779D
Stock Option (Right to Buy)F12$106.59holding————Aug 18, 2023Common Stock154,169154,169D
Restricted Stock UnitF10,F12—holding—————Common Stock24,97924,979D

Explanation of responses